Evidence map›Paper›PMID 35406730›Full record

ArticleCells2022

Alterations in Protein Translation and Carboxylic Acid Catabolic Processes in Diabetic Kidney Disease.

Kimberly S Collins, Michael T Eadon, Ying-Hua Cheng, Daria Barwinska, Ricardo Melo Ferreira, Thomas W McCarthy, Danielle Janosevic, Farooq Syed, Bernhard Maier, Tarek M El-Achkar and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Kimberly S CollinsDivision of Nephrology and Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Michael T EadonDivision of Nephrology and Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0003-3066-2876
Ying-Hua ChengDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Daria BarwinskaDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Ricardo Melo FerreiraDivision of Nephrology and Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Thomas W McCarthyDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Danielle JanosevicDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Farooq SyedDepartment of Pediatrics and Herman B. Wells Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0002-0284-0631
Bernhard MaierDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Tarek M El-AchkarDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Katherine J KellyDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Carrie L PhillipsDepartment of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Takashi HatoDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Timothy A SuttonDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Pierre C DagherDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Indiana University School of Medicine

Funding

Coordinating and Bioinformatics Unit for the MMPC/DiaCompU24DK076169 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2006 to 2018
$42.4M
ConProject-002U2CDK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN, IYENGAR, SRINIVAS RAVI V · 2017 to 2021
$21.0M
Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney.UH3DK114923 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI ASHKAR, TAREK MAURICE, DAGHER, PIERRE C · 2019 to 2021
$2.2M
Modifying kidney injury through p53 signaling.R01DK099345 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI DAGHER, PIERRE C, SUTTON, TIMOTHY ALAN · 2014 to 2017
$1.4M
Acute inhibition of renal gene expression to prevent nephrotoxicity.K08DK107864 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EADON, MICHAEL THOMAS · 2016 to 2020
$772k
NIDDK NIH HHS K08 DK107864NIDDK NIH HHS R01 DK099345NIDDK NIH HHS U24 DK076169NIDDK NIH HHS U2C DK114886NIDDK NIH HHS UH3 DK114923
6 · The paper itself

Abstract

Diabetic kidney disease (DKD) remains the leading cause of end-stage kidney disease despite decades of study. Alterations in the glomerulus and kidney tubules both contribute to the pathogenesis of DKD although the majority of investigative efforts have focused on the glomerulus. We sought to examine the differential expression signature of human DKD in the glomerulus and proximal tubule and corroborate our findings in the db/db mouse model of diabetes. A transcriptogram network analysis of RNAseq data from laser microdissected (LMD) human glomerulus and proximal tubule of DKD and reference nephrectomy samples revealed enriched pathways including rhodopsin-like receptors, olfactory signaling, and ribosome (protein translation) in the proximal tubule of human DKD biopsy samples. The translation pathway was also enriched in the glomerulus. Increased translation in diabetic kidneys was validated using polyribosomal profiling in the db/db mouse model of diabetes. Using single nuclear RNA sequencing (snRNAseq) of kidneys from db/db mice, we prioritized additional pathways identified in human DKD. The top overlapping pathway identified in the murine snRNAseq proximal tubule clusters and the human LMD proximal tubule compartment was carboxylic acid catabolism. Using ultra-performance liquid chromatography-mass spectrometry, the fatty acid catabolism pathway was also found to be dysregulated in the db/db mouse model. The Acetyl-CoA metabolite was down-regulated in db/db mice, aligning with the human differential expression of the genes ACOX1 and ACACB. In summary, our findings demonstrate that proximal tubular alterations in protein translation and carboxylic acid catabolism are key features in both human and murine DKD.

Indexed as

Diabetes MellitusDiabetic NephropathiesAnimalsCarboxylic AcidsKidneyKidney GlomerulusMiceProtein BiosynthesisCarboxylic Acidsgene expression signaturemetabolomicsribosomal profilingsingle nuclear RNA sequencing

Identifiers

PMID35406730
PMCPMC8997785
OpenAlexW4226144764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.